Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
1.910
+0.050 (2.69%)
At close: Nov 22, 2024, 4:00 PM
1.990
+0.080 (4.18%)
After-hours: Nov 22, 2024, 6:33 PM EST
Lifeward Revenue
Lifeward had revenue of $6.13M in the quarter ending September 30, 2024, with 39.18% growth. This brings the company's revenue in the last twelve months to $25.00M, up 173.28% year-over-year. In the year 2023, Lifeward had annual revenue of $13.85M with 151.39% growth.
Revenue (ttm)
$25.00M
Revenue Growth
+173.28%
P/S Ratio
0.64
Revenue / Employee
$231,500
Employees
108
Market Cap
16.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | 4.87M | -1.67M | -25.55% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cumberland Pharmaceuticals | 36.79M |
| Marinus Pharmaceuticals | 31.47M |
| Ekso Bionics Holdings | 17.68M |
| Nephros | 13.55M |
| Cara Therapeutics | 8.69M |
| Synlogic | 2.78M |
| Aprea Therapeutics | 1.31M |
LFWD News
- 3 days ago - Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons - GlobeNewsWire
- 10 days ago - Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Lifeward Ltd. Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 17 days ago - Lifeward to Report Third Quarter Financial Results on November 12, 2024 - GlobeNewsWire
- 4 weeks ago - Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024 - GlobeNewsWire
- 2 months ago - Lifeward Launches Direct Sales of AlterG Product Line in Germany - GlobeNewsWire
- 2 months ago - ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd. - GlobeNewsWire
- 2 months ago - Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research - GlobeNewsWire